CIBC World Markets’s Jazz Pharmaceuticals JAZZ Stock Holding History

CIBC World Markets’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,449	Closed	-$295K	–	746
2024 Q1	$295K	Buy	2,449 +778	+47%	+$95.3K	﹤0.01%	775
2023 Q4	$206K	Buy	+1,671	New	+$209K	﹤0.01%	739
2021 Q3	–	Sell	-12,100	Closed	-$2.15M	–	622
2021 Q2	$2.15M	Sell	12,100 -6,048	-33%	-$1.05M	0.02%	416
2021 Q1	$2.98M	Buy	+18,148	New	+$2.99M	0.02%	378
2020 Q1	–	Sell	-16,000	Closed	-$2.39M	–	651
2019 Q4	$2.39M	Buy	+16,000	New	+$2.18M	0.02%	553
2019 Q3	–	Sell	-2,818	Closed	-$402K	–	689
2019 Q2	$402K	Buy	+2,818	New	+$379K	﹤0.01%	666
2016 Q4	–	Sell	-92,047	Closed	-$11.2M	–	609
2016 Q3	$11.2M	Buy	+92,047	New	+$12.4M	0.21%	111

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

CIBC World Markets's JAZZ Position: Q2 2024 in Review

CIBC World Markets sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2024, closing a stake of 2,449 shares — an estimated $295K sold.

CIBC World Markets first reported a position in JAZZ in Q3 2016 and held it in 7 quarters. The position peaked at $11.2M in Q3 2016. 456 funds tracked by Wall St. Rank hold JAZZ as of Q2 2024.

CIBC World Markets reported no remaining Jazz Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
CIBC World Markets sold 2,449 Jazz Pharmaceuticals shares in Q2 2024, an estimated $295K.
CIBC World Markets first reported a position in Jazz Pharmaceuticals in Q3 2016 and held it in 7 quarters.
CIBC World Markets's Jazz Pharmaceuticals position peaked at $11.2M in Q3 2016.
456 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2024.

Based on CIBC World Markets's 13F filing for Q2 2024, filed 12 Aug 2024.